Hong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May

https://endpts.com/hong-kong-clears-way-for-pre-revenue-biotech-ipos-plans-to-accept-listing-applications-by-may/

"Under new rules, pre-revenue biotechs can apply for IPOs as long as they are valued at HK$1.5 billion (US$192 million), backed by a senior investors, and have a Phase I study under their belt with a green light to embark on Phase II. Other criteria include being at least two-years old and having some patents."

Interesting article. Thanks for sharing on IV rndtbl.